Centre d'Exploration et d'Évaluation Neuromusculaire
Paris, France
Location status: Recruiting
NCT Number: NCT07321977
In recent years, knowledge of neuromuscular diseases has advanced considerably, and new therapeutic avenues are beginning to emerge. The proliferation of clinical trials has created a need to identify biomarkers that are both sensitive to changes and specific to the disease. Current gait tests only consider the time factor and not the evolution of the patient's biomechanics, which may prove insufficient for patients whose symptoms generally progress slowly. Quantifying gait parameters in neuromuscular patients therefore appears necessary. This is why we propose to study markerless gait analysis in this population, which would allow for simple and effective monitoring of kinematic parameters without resorting to complex equipment incompatible with routine clinical practice.
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Not applicable
Paris, France
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Exclusion criteria
Exclusion criteria
Using motion analysis software integrated into a smartphone
Time frame: Day 1
Correlation coefficient between measurements from the two systems in both groups, for spatiotemporal parameters and joint range of motion in the sagittal plane at the hip, knee, and ankle
Contact information is provided by the study sponsor or research team.
Pauline SANTMARTY, MsC
CONTACT
Romain FEIGEAN, PhD
CONTACT
Institut de Myologie, France
Other
Acronym: Myokinesis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06666816
Central Nervous System Diseases, Charcot Marie Tooth Disease
Bosisio Parini, Lecco, Italy
View Trial DetailsNCT07356063
Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
View Trial DetailsNCT07072676
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Bad Feilnbach, Germany
View Trial DetailsNCT07287982
Central Nervous System Diseases, Motor Neuron Disease
Little Rock, Arkansas, United States
View Trial Details